Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market
Holding RXRX?
Track your performance easily

Recursion Pharmaceuticals (RXRX) Financial Statements

1,775 Followers

Recursion Pharmaceuticals Financial Overview

Recursion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.622; its P/E ratio is -3.99; Recursion Pharmaceuticals is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 14.42M$ 13.79M$ 10.62M$ 10.53M$ 11.02M
Gross Profit$ 5.22M$ 2.63M$ 743.00K$ -344.00K$ 1.64M
EBIT$ -97.69M$ -92.13M-$ -92.99M$ -81.63M
EBITDA$ -88.72M$ -84.75M--$ -76.09M
Net Income Common Stockholders$ -97.54M$ -91.37M$ -93.00M$ -93.02M$ -76.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 474.34M$ 296.33M$ 391.56M$ 387.32M$ 409.19M
Total Assets$ 775.86M$ 557.85M$ 653.70M$ 630.83M$ 666.70M
Total Debt$ 89.88M$ 50.97M$ 50.67M$ 51.48M$ 52.90M
Net Debt$ -384.46M$ -245.35M$ -340.89M$ -335.85M$ -356.30M
Total Liabilities$ 191.41M$ 156.70M$ 190.26M$ 192.86M$ 197.74M
Stockholders Equity$ 540.98M$ 401.15M$ 463.44M$ 437.97M$ 468.97M
Cash Flow-
Free Cash Flow$ -86.40M$ -108.95M--$ -71.44M
Operating Cash Flow$ -82.22M$ -102.30M$ -74.08M$ -72.92M$ -67.47M
Investing Cash Flow$ -4.18M$ -6.65M$ -2.49M$ -347.00K$ -2.05M
Financing Cash Flow$ 263.12M$ 13.90M$ 80.66M$ 53.77M$ 3.79M
Currency in USD

Recursion Pharmaceuticals Earnings and Revenue History

Recursion Pharmaceuticals Debt to Assets

Recursion Pharmaceuticals Cash Flow

Recursion Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis